Snapshot from Jul 19, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / ADMA Biologics class action lawsuit
Regulatory securities class action

ADMA Biologics class action lawsuit

Analysis based on 6 articles · First reported Jul 06, 2026 · Last updated Jul 10, 2026

Sentiment
-30
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The lawsuit may negatively impact ADMA Biologics' stock price and investor confidence. The allegations of channel stuffing and inadequate controls could lead to regulatory scrutiny and potential financial penalties.

Biotechnology Pharmaceuticals
Event Summary

A class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ: ADMA) and certain of its officers by Bronstein, Gewirtz & Grossman, LLC, LLC, a nationally recognized investor-rights law firm. The lawsuit alleges violations of federal securities laws on behalf of all persons and entities that purchased or acquired ADMA securities between August 9, 2024 and March 25, 2026. The complaint claims that ADMA Biologics engaged in an undisclosed related party transaction, used channel stuffing to inflate revenue, and lacked adequate internal controls, making statements about its business materially false and misleading. Investors have until August 10, 2026 to request lead plaintiff appointment.

Key Actions
80 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit ADMA Biologics
Entities Involved
stock
ADMA Biologics
ADMA Biologics is the defendant in the class action lawsuit, facing allegations of securities fraud. The company's reputation and stock price may suffer as a result.
Importance 100.0 Sentiment -50.0
priv
Bronstein, Gewirtz & Grossman, LLC
Bronstein, Gewirtz & Grossman, LLC is the law firm that filed the class action lawsuit on behalf of investors. The firm seeks to recover damages and may gain visibility from this case.
Importance 50.0 Sentiment 10.0
per
Peretz Bronstein
Peretz Bronstein is the founding partner of Bronstein, Gewirtz & Grossman, LLC and is involved in representing investors in this class action.
Importance 20.0 Sentiment 5.0
per
Nathan Miller
Nathan Miller is a client relations manager at Bronstein, Gewirtz & Grossman, LLC, serving as a contact for investors interested in joining the lawsuit.
Importance 10.0 Sentiment 0.0
Relationships
Bronstein, Gewirtz & Grossman, LLC related ↔ Peretz Bronstein
Bronstein, Gewirtz & Grossman, LLC related ↔ Nathan Miller
Peretz Bronstein employer ↔ Nathan Miller Peretz Bronstein is a founding partner of Bronstein, Gewirtz & Grossman, LLC, where he employs and directs Nathan Miller
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.